Wilms' tumor gene 1 (WT1), which was once thought to be a tumor suppressor gene causing Wilms' tumor, is one of the most promising TAAs that has been identified as a target for cancer immunotherapy [7]. This evidence concerns the gene WT1 and Nephroblastoma.